Enhanced myocardial preservation by nicotinic acid, an antilipolytic compound: Mechanism of action
- 1 January 1989
- journal article
- research article
- Published by Springer Nature in Basic Research in Cardiology
- Vol. 84 (1) , 63-76
- https://doi.org/10.1007/bf01907004
Abstract
The cardioprotective effects of an antilipolytic compound, nicotinic acid, on arrested-reperfused myocardium were investigated in the isolatedin situ pig heart preparation. Hearts were preperfused for 15 min in the presence of (5-3H)-glucose and (U-14C)-palmitic acid. Half of the hearts were then perfused with 0.08 mM nicotinic acid for an additional 15-min period, while the remaining control hearts received unmodified perfusion. Arrest was then induced in all animals for 2 h using hypothermic K+ cardioplegia, followed by 60 min of normothermic reperfusion. In control hearts, there were significantly greater levels of long-chain acyl Co-A and acyl carnitine and lower levels of membrane phospholipids than in the nicotinic acid group. While nicotinic acid inhibited β-oxidation during pre-ischemia and reperfusion, it also prevented the degradation of membrane phospholipids. The net result was a reduction of free fatty acid accumulation during arrest and reperfusion in the nicotinic acid group. Glycolysis, as reflected in3H2O production, was significantly increased by nicotinic acid administration. In the control heart as compared to the nicotinic acid group, the incorporation of14C-label from palmitate into triglyceride and cholesterol during arrest was enhanced, while incorporation into phospholipids was depressed. The cardioprotective effects of nicotinic acid were demonstrated by decreased release of creatine kinase and improved coronary blood flow, and cardiac contractility in the reperfused myocardium supplemented with nicotinic acid compared to the control group. These results suggest that nicotinic acid significantly protects the arrested-reperfused myocardium by a) preventing elevation of myocardial fatty acid levels, b) stimulating glycolysis by limiting fatty acid oxidation, c) inhibiting degradation of membrane phospholipids, and d) preventing accumulation of fatty acid metabolites with harmful detergent properties.This publication has 40 references indexed in Scilit:
- Enhanced prostaglandin synthesis due to phospholipid breakdown in ischemic-reperfused myocardium†Control of its production by a phospholipase inhibitor of free radical scavengersJournal of Molecular and Cellular Cardiology, 1986
- Effect of ischemia on fatty acid metabolism in fetal lungLife Sciences, 1983
- Arrhythmogenic amphiphilic lipids and the myocardial cell membraneJournal of Molecular and Cellular Cardiology, 1982
- Fatty acid effects on membranes: Possible role in the pathogenesis of ischemic myocardial damageJournal of Molecular and Cellular Cardiology, 1982
- Effect of antilipolytic therapy on ST segment elevation during myocardial ischaemia in man.Heart, 1978
- Effect of glucose-insulin-potassium infusions on arteriovenous differences of glucose and of free fatty acids and on tissue metabolic changes in dogs with developing myocardial infarctionThe American Journal of Cardiology, 1976
- CONTROL OF VENTRICULAR ARRHYTHMIAS DURING MYOCARDIAL INFARCTION BY ANTILIPOLYTIC TREATMENT USING A NICOTINIC-ACID ANALOGUEThe Lancet, 1975
- Effect of Free Fatty Acids on Myocardial Function and Oxygen Consumption in Intact DogsJournal of Clinical Investigation, 1971
- Myocardial uptake and fractional distribution of palmitate-1-C14 by the ischemic dog heartMetabolism, 1966
- Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarctionThe American Journal of Cardiology, 1962